Search Results - "Alexandrova, G.I."

Current strategies for the prevention of influenza by the Russian cold-adapted live influenza vaccine among different populations by Rudenko, L.G, Alexandrova, G.I

“…Trivalent live attenuated influenza vaccine (LIV) prepared from the donor strains A/Len/134/17/57 (H2N2) and B/USSR/60/69 demonstrated safety, immunogenicity,…”
Get full text

Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus by Klimov, A.I, Kiseleva, I.V, Alexandrova, G.I, Cox, N.J

“…Background: The A/Leningrad/134/17/57 (H2N2) (Len/17) cold-adapted (ca) master strain used as a donor of attenuation for preparing live attenuated influenza…”
Get full text

Analysis of some factors influencing immunogenicity of live cold-adapted reassortant influenza vaccines by Rudenko, L.G, Kiseleva, I.V, Larionova, N.V, Grigorieva, E.P, Naikhin, A.N, Alexandrova, G.I

“…Inability to grow at elevated temperature (temperature sensitivity or ts phenotype) is an important characteristic of wild-type ( wt) viruses. Analysis of our…”
Get full text

Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines by Desheva, J.A, Rudenko, L.G, Alexandrova, G.I, Lu, X, Rekstin, A.R, Katz, J.M, Cox, N.J, Klimov, A.I

“…To prepare candidate influenza pandemic vaccines, we are developing an approach based on reassortment of antigenically appropriate nonpathogenic avian viruses…”
Get full text

Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age by Klimov, A.I., Kiseleva, I.V., Desheva, J.A., Alexandrova, G.I., Cox, N.J., Rudenko, L.G.

“…Background: Live influenza A vaccines (LIVs) for adults and children are prepared in Russia by reassorting current epidemic strains with cold-adapted (ca)…”
Get full text

Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88 by Slepushkin, A N, Obrosova-Serova, N P, Burtseva, E I, Rudenko, L G, Govorkova, E A, Vartanyan, R V, Verestsinsky, A I, Lonskaya, N I, Harmon, M W, Torok, T

“…The performance of two doses of cold-adapted live attenuated vaccine versus one dose of whole-virus inactivated vaccine was compared in 8-15-year-old…”
Get more information

Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates by Alexandrova, G I, Maassab, H F, Kendal, A P, Medvedeva, T E, Egorov, A Y, Klimov, A I, Cox, N J

“…The adaptation of two influenza B strains (B/Leningrad/14/55 and B/Ann Arbor/1/66) to replication at 25 degrees C is described. Comparison of the two viruses…”
Get more information

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial by Alexandrova, G I, Budilovsky, G N, Koval, T A, Polezhaev, F I, Garmashova, L M, Ghendon YuZ, Romanova, Y R, Smorodintsev, A A

“…Live cold-adapted recombinant bivalent vaccine of influenza type A was studied in a controlled field trial in 1982-1983 among nearly 30,000 children 3-15 years…”
Get more information

Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses by Obrosova-Serova, N P, Slepushkin, A N, Kendal, A P, Harmon, M W, Burtseva, E I, Bebesheva, N I, Beljaev, A L, Lonskaja, N I, Medvedeva, T E, Egorov, A Y

“…A reassortant cold-adapted (ca) influenza B experimental live attenuated intranasal vaccine was evaluated for safety and immunogenicity in children by means of…”
Get more information

Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain by Slepushkin, A N, Patriarca, P A, Obrosova-Serova, N P, Harmon, M W, Kupryashina, L N, Cheshik, S G, Vartanyan, R B, Alexandrova, G I, Polezhaev, F I, Lonskaya, N I

“…Forty-three school children from 8 to 11 years old were vaccinated intranasally with two doses of a paediatric attenuated influenza vaccine developed by…”
Get more information